Human Reproduction, Vol. 14, No. 12, 2959-2962,
December 1999
© 1999 European Society of Human Reproduction and Embryology
Will GnRH antagonists provide new hope for patients considered `difficult responders' to GnRH agonist protocols?
London Gynaecology & Fertility Centre, Cozens House, 112a Harley Street, London W1N 1AF, UK
We have assessed the use of cetrorelix, a gonadotrophin releasing hormone (GnRH) antagonist, in conjunction with clomiphene citrate and gonadotrophin in 31 in-vitro fertilization (IVF)/gamete intra-Fallopian transfer (GIFT) cycles for 25 difficult responders. Group I included 18 poor responders (24 cycles) with no live birth in 23 previous IVF cycles with GnRH agonists. Group II included seven patients (seven cycles) with polycystic ovaries. Thirteen previous IVF/GIFT cycles with GnRH agonists had resulted in one live birth and three of these patients had developed ovarian hyperstimulation syndrome (OHSS). The treatment protocol involved a daily dose of clomiphene citrate 100 mg for 5 days and gonadotrophin injections from cycle day 2. Cetrorelix 0.25 mg/day was started when the leading follicle reached 14 mm. The outcome in both groups was favourable compared to previous treatment with GnRH agonists. In group I the abandoned cycle rate was 29 versus 57% (P = 0.06). More oocytes were produced (6.4 versus 4.7 oocytes/cycle) at a lower dose of follicle-stimulating hormone (FSH) (709 versus 1163 IU/oocyte; P = 0.08) and two live births resulted (11.8%). In group II fewer oocytes were produced (10.2 versus 14.5 oocytes/cycle), using a lower dose of gonadotrophin (170 versus 189 IU/oocyte) and resulted in one ongoing pregnancy. No patients experienced OHSS. This report is preliminary and a further controlled randomized study is required.
Key words: GnRH antagonist/ovarian hyperstimulation syndrome/polycystic ovary/protocols/difficult responders
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L.-P. Cheung, P.-M. Lam, I. H. Lok, T. T.-Y. Chiu, S.-Y. Yeung, C.-C. Tjer, and C. J. Haines GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial Hum. Reprod., March 1, 2005; 20(3): 616 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Hwang, K.-M. Seow, Y.-H. Lin, L.-W. Huang, B.-C. Hsieh, Y.-L. Tsai, G.-J. Wu, S.-C. Huang, C.-Y. Chen, P.-H. Chen, et al. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study Hum. Reprod., September 1, 2004; 19(9): 1993 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Hwang, L.-W. Huang, B.-C. Hsieh, Y.-L. Tsai, S.-C. Huang, C.-Y. Chen, M.-L. Hsieh, P.-H. Chen, and Y.-H. Lin Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles Hum. Reprod., January 1, 2003; 18(1): 45 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mantoudis, B.T. Podsiadly, A. Gorgy, G. Venkat, and I.L. Craft A comparison between quarter, partial and total laser assisted hatching in selected infertility patients Hum. Reprod., October 1, 2001; 16(10): 2182 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fujii, S. Sato, A. Fukui, H. Kimura, G. Kasai, and Y. Saito Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF Hum. Reprod., August 1, 2001; 16(8): 1671 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Akman, H. F. Erden, S. B. Tosun, N. Bayazit, E. Aksoy, and M. Bahceci Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial Hum. Reprod., May 1, 2001; 16(5): 868 - 870. [Abstract] [Full Text] [PDF]
|
|